Verdict86/ 100
Grade B · #6Sprout Health
A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.
Visit Sprout HealthHead-to-head verdict
Sprout Health vs Gala Health
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict86/ 100
Grade B · #7Gala Health
A cheap compounded entry with a real brand-Ozempic path and nationwide coverage — but the $179 is a yearly-subscription rate, and Gala publishes no month-to-month price at all, which is what the verdict now docks it hardest for.
Visit Gala HealthThe verdict
Too close to call. Sprout Health and Gala Health land on the same Verdict Score of 86/100, so this one comes down to your priorities rather than our scoreboard. Weigh the factor-by-factor breakdown and pricing below — patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
82Real-world results85
82
Real-world results85
90Price honesty87
90
Price honesty87
82Prescriber access88
82
Prescriber access88
86Formulary choice88
86
Formulary choice88
80Cancellation fairness84
80
Cancellation fairness84
78Member support84
78
Member support84
Price, coverage & features
| Metric | Sprout Health | Gala Health |
|---|---|---|
| Verdict Score | 86/100 | 86/100 |
| Grade | B | B |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $199/mo | $179/mo (annual) |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | No | No |
Sprout Health
What we like
- LegitScript-certified with a listed address and contact line
- Both compounded ($149 semaglutide / $199 tirzepatide) and a genuine brand-name Wegovy/Zepbound route
- Low-friction intake — no labs and often no telehealth visit required
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved
- No oral or sublingual route — injectable only
- Thin transparency — no named medical director, and state availability is quiz-gated
- "No labs, no visit" convenience also means lighter clinical oversight
Gala Health
What we like
- Low compounded entry at $179/mo — on a yearly subscription — with all doses included, so titrating up costs nothing extra
- Available in all 50 states, so access never blocks the sign-up
- Offers a real FDA-approved brand path (Ozempic) alongside the compounded track, which most compounded-only programmes cannot
- Adjacent HRT and menopause care for patients who want more than a GLP-1 alone
The caveats
- The $179 requires a yearly subscription — no month-to-month rate is published, and the cheapest term quoted in prose is $199/mo on a 3-month plan
- The $149 'microdose' tier is sub-therapeutic — a longevity protocol, not a cheaper weight-loss dose
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- Brand Ozempic runs $1,299/mo, and the dispensing pharmacy is never named — vet it yourself
Our pick — visit
Patients who want a low compounded entry price but the option of brand-name Wegovy or Zepbound on the same account, with minimal onboarding.
Visit Sprout Health Read the full Sprout Health review →Our pick — visit
Patients in any state willing to commit to a year up front for a low compounded tirzepatide rate, while keeping a legitimate brand-name option on the table.
Visit Gala Health Read the full Gala Health review →Keep comparing
Neither of these has to be the answer: the rivals we rank against Sprout Health cover the 7 programmes closest to it, and the same shortlist for Gala Health does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.